AZITHROMYCIN INCREASES CHLORIDE EFFLUX FROM CYSTIC FIBROSIS AIRWAY EPITHELIAL CELLS
- 1 January 2009
- journal article
- clinical trial
- Published by Taylor & Francis in Experimental Lung Research
- Vol. 35 (3) , 210-221
Abstract
It was investigated whether azithromycin (AZM) stimulates chloride (Cl−) efflux from cystic fibrosis (CF) and non-CF airway epithelial cells, possibly secondary to up-regulation of the multidrug resistance protein (MDR). CF and non-CF human airway epithelial cell lines (CFBE and 16HBE) were treated with 0.4, 4, and 40 μ g/mL AZM for 4 days. Cl− efflux was explored in the presence or absence of specific inhibitors of CFTR and alternative Cl− channels. Six CF patients received AZM (500 mg daily) for 6 months. The percentage of predicted forced vital capacity (FVC%), forced expiratory volume (FEV1%), and the number of acute exacerbations were compared before and after treatment. Nasal biopsies were taken before and after treatment, and mRNA expression of MDR and CFTR was determined by in situ hybridization. A significant dose-dependent increase of Cl− efflux from CFBE cells (but not from 16HBE cells) was observed after AZM treatment. A CFTR inhibitor significantly reduced AZM-stimulated Cl− efflux from CFBE cells. A significant improvement in FEV1%, and fewer exacerbations were observed. AZM treatment did not affect mRNA expression of MDR and CFTR. The stimulation of Cl− efflux could be part of the explanation for the clinical improvement seen among the patients.Keywords
This publication has 42 references indexed in Scilit:
- Decrease of elastic moduli of DOPC bilayers induced by a macrolide antibiotic, azithromycinBiochimica et Biophysica Acta (BBA) - Biomembranes, 2007
- Cystic fibrosis: the mechanisms of pathogenesis of an inherited lung disorderDrug Discovery Today: Disease Mechanisms, 2007
- Long term effects of azithromycin in patients with cystic fibrosis: a double blind, placebo controlled trialThorax, 2006
- Novel Effects of Azithromycin on Tight Junction Proteins in Human Airway EpitheliaAntimicrobial Agents and Chemotherapy, 2006
- Azithromycin Exhibits Bactericidal Effects on Pseudomonas aeruginosa through Interaction with the Outer MembraneAntimicrobial Agents and Chemotherapy, 2005
- Azithromycin Retards Pseudomonas aeruginosa Biofilm FormationJournal of Clinical Microbiology, 2004
- Azithromycin for cystic fibrosisEuropean Respiratory Journal, 2004
- Pharmacologic therapy for stop mutations: how much CFTR activity is enough?Current Opinion in Pulmonary Medicine, 2004
- A non‐capacitative pathway activated by arachidonic acid is the major Ca2+ entry mechanism in rat A7r5 smooth muscle cells stimulated with low concentrations of vasopressinThe Journal of Physiology, 1999
- BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTERAnnual Review of Pharmacology and Toxicology, 1999